Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: Part 1 (week 12) of the CLIPPER study

  • Gerd Horneff
  • , Ruben Burgos-Vargas
  • , Tamas Constantin
  • , Ivan Foeldvari
  • , Jelena Vojinovic
  • , Vyacheslav G. Chasnyk
  • , Joke Dehoorne
  • , Violeta Panaviene
  • , Gordana Susic
  • , Valda Stanevica
  • , Katarzyna Kobusinska
  • , Zbigniew Zuber
  • , Richard Mouy
  • , Ingrida Rumba-Rozenfelde
  • , Luciana Breda
  • , Pavla Dolezalova
  • , Chantal Job-Deslandre
  • , Nico Wulffraat
  • , Daniel Alvarez
  • , Chuanbo Zang
  • Joseph Wajdula, Deborah Woodworth, Bonnie Vlahos, Alberto Martini, Nicolino Ruperto (Corresponding Author)

Research output: Contribution to journalArticlepeer-review

115 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: Part 1 (week 12) of the CLIPPER study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science